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Abstract 
Background: Although long term outcome studies in large pediatric 
myocarditis/cardiomyopathy populations have been reported in literature, none of them 
focused on comorbidities. Methods: All children and adolescents (age <18 years) treated with 
myocarditis at the Department of Pediatrics, University of Debrecen, Hungary were followed. 
Patients suffering from myocarditis during the period 1996–2011 were enrolled. Results: 
Over the 16-year period, a diagnosis of myocarditis was established in nine children. Their 
median age was 1.11 (0.03–8.71) years. Three of the nine patients died. Left ventricular 
dilatation and ejection fraction normalized within 1–21 months in the survivors. None of the 
cases progressed to dilated cardiomyopathy. Regarding non-cardiac comorbidities, 
myocarditis or recurrent peri-myocarditis preceded the manifestation of celiac disease in two 
patients, while cystic fibrosis was diagnosed after the improvement of cardiac function in 
another, and Alström syndrome was diagnosed several years after complete recovery from 
myocarditis in yet another patient. Conclusion: These results suggest that manifestations of 
other chronic pediatric diseases may be more frequent among survivors of pediatric 
myocarditis. Prolonged follow-up of patients who survive myocarditis is therefore 
recommended not only to detect possible progression to cardiomyopathy, but also to identify 
non-cardiac comorbidities. 
 
Keywords: myocarditis, child, celiac disease, cystic fibrosis, Alström syndrome, Kawasaki 
disease 
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Introduction 
Although long term outcome studies in large pediatric myocarditis/cardiomyopathy 
populations have been reported in literature, none of them focused on comorbidities [1-4]. A 
recent pediatric study showed that children with myocarditis/cardiomyopathy may have celiac 
disease (prevalence 1.8%) [5]. Another report suggested that celiac disease, which is often 
clinically unsuspected, accounts for as many as 5-5.7% of adult patients with autoimmune 
myocarditis [6,7].  Information on possible other comorbidities that may influence recovery is 
scarce. Prolonged follow-up results presented an opportunity to gather additional information 
regarding the coexistence of non-cardiac diseases in pediatric myocarditis. The clinical 
characteristics of patients with pediatric myocarditis treated at the Department of Pediatrics, 
University of Debrecen were studied to shed new light on the course of this illness and the 
possible comorbidities.  
 
Methods 
Patients and data collection 
We retrospectively followed all children and adolescents (age <18 years) with myocarditis 
treated at the Department of Pediatrics, University of Debrecen, Hungary. Patients suffering 
from myocarditis during the period 1996–2011 were enrolled. The inclusion criteria were 
patients with myocarditis who had been followed for the entire period of their cardiac care. 
Myocarditis was defined as severe cardiac dysfunction or regional wall motion abnormality 
seen on echocardiography, with the exclusion of other causes such as coronary disease, sepsis, 
metabolic heart disease, congenital malformation and a history of cardiomyopathy. All the 
nine study patients had a recent history of viral illness, and the six survivors had complete 
recovery of their cardiac function. In two of three fatal cases, autopsies were performed, 
which included histologic evaluation of the heart. Data collection considered all hospital 
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records, including outpatient notes and hospital progress notes, as well as cardiology and 
radiology reports.  
The authors of this manuscript have certified that they comply with the principles of ethical 
publishing in Interventional Medicine & Applied Science: Szél Á, Merkely B, Hüttl K, Gál J, 
Nemes B, Komócsi A: Statement on ethical publishing and scientific authorship. IMAS 2, 
101-102 (2010). 
 
Results 
A total of nine children (5 girls and 4 boys) were admitted to the hospital with a diagnosis of 
myocarditis between January 1996 and December 2011. The median age of the patients was 
1.11 years (range 0.03–8.71 years), and the median follow-up time was 11.52 years (range 
1.6–16.2 years). The incidence rate of hospital discharges diagnosed with myocarditis at the 
Department of Pediatrics, University of Debrecen, Hungary was 1/10,000 (1996–2011).  
 
Primary clinical symptoms 
The primary symptoms included poor feeding and lethargy in eight patients, tachypnea in six, 
and chest pain in one 8-year-old child (Table I). This last patient was shown to have peri-
myocarditis by non-invasive evaluation. Three of the nine patients were only admitted at their 
second outpatient visit, because myocarditis was not suspected at their first visit.  
 
Cardiology and laboratory findings  
All patients had abnormal electrocardiograms on admission. Each patient had sinus 
tachycardia and ST-T abnormalities, and four of them showed low voltage. Cardiomegaly was 
detected in six patients and prominent right atrium in two others by chest x-ray.  
 Echocardiography detected systolic dysfunction of the left ventricle in eight patients 
and regional wall motion abnormalities with pericardial effusion in one other. Three patients 
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with acute fulminant myocarditis had poor ventricular function but no ventricular dilatation. 
Normal left ventricle size was identified in the patient with recurrent peri-myocarditis. All 
patients had mitral regurgitation. Cardiac enzymes or troponin were checked in eight patients 
and were positive in six (Table I). 
 Myocardial biopsy was not performed in any patients. Among the three fatal cases, 
histological examinations at autopsy in two showed myocytolysis with acute inflammatory 
cell (leukocyte common antigen-positive) infiltration in one case, and severe myocytolysis 
without inflammatory cellular infiltrate in the other. No autopsy was performed in the third 
case because of the lack of parental informed consent. 
 Cardiac magnetic resonance imaging (MRI) in one patient with recurrent peri-
myocarditis revealed delayed enhancement in the anterior wall of the LV 142 days after the 
onset of the second episode.  
 Serology for viruses was performed in each patient. Two patients had acute adenovirus 
infection and another had influenza A virus infection. 
 
Acute treatment 
The standard treatment for each patient included furosemide, digoxin and an angiotensin 
converting enzyme inhibitor. Six of the nine patients received dopamine-dobutamine and one 
received milrinone infusion. Steroids were administered to two patients during the acute 
phase because of cardiac shock, and to two other patients during the subacute phase (from 
days 10–14 of the disease for 60 days). Intravenous immunoglobulin was given to four 
patients during the acute phase. Mechanical ventilation was administered to three patients. 
The patient with peri-myocarditis received a non-steroidal antiinflammatory agent (Table II). 
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Acute clinical course  
Three patients died of cardiogenic shock during the acute phase of the disease (days 1, 2 and 8 
following admission, respectively). The clinical pictures in Patients 5, 8 and 9 fulfilled the 
diagnosis of acute fulminant myocarditis (Table I-III). One patient subsequently developed a 
left ventricular thrombus and cerebral embolization, but the intracardiac thrombus resolved 
after heparin therapy (Patient 2). This patient still had mild residual right-sided hemiparesis 
12 years after the stroke. Episodes of atrial tachycardia developed in a newborn and lasted for 
5 days. No serious complications occurred during the acute phase of the disease in four cases.  
 
Left ventricular function 
Recovery from the severe initial left ventricular dysfunction (fractional shortening > 30%) in 
the five survivors took 22–510 days (median 150 days). In the sixth survivor with recurrent 
peri-myocarditis, regional wall motion abnormalities disappeared on days 11 and 18, 
respectively. The mitral regurgitation detected on the second occasion had also disappeared 
by day 18. 
 None of the survivors developed dilated cardiomyopathy during the follow-up period. 
   
Long-term follow-up: 
Patient 1. A 4-month-old girl (Patient 1) developed heart failure with elevated cardiac 
enzymes (aspartate aminotransferase and alpha hydroxybutyrate dehydrogenase) and left 
ventricle dysfunction (Table 3). Her cardiac function improved gradually as a result of anti-
congestive treatment including dopamine, and fractional shortening was 30% after 120 days. 
Her LV size and systolic function remained normal during the next 15 years. However, 
gradual visual impairment was detected from the age of 2 years, diagnosed as Leber’s 
congenital amaurosis. Hypacusis was detected at age 7 years, which was explained by 
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respiratory obstruction due to recurrent tonsillitis. She was also evaluated for obesity and 
dyslipidemia (cholesterol: 8.1 mmol/l, triglycerides 3.7 mmol/l), impaired glucose tolerance 
(120-min blood sugar 11.1 mmol/l), and latent hypothyreosis (circulating thyroid-stimulating 
hormone 4.6 mU/l, free thyroxine 11.6 pmol/l). At the age of 11 years, manifest type 2 
diabetes mellitus was diagnosed (fasting blood sugar 17.5 mmol/l) and diet therapy and 
metformin were initiated. Based on a review of her symptoms, Alström syndrome was 
verified. 
Patient 2. This patient developed a left ventricular thrombus and cerebral embolization during 
the acute phase of the disease. The intracardiac thrombus resolved with heparin therapy, but 
the patient still had mild residual right-sided hemiparesis 12 years after the stroke. 
Patient 3. This 11-month-old boy, whose left ventricle function recovered within 150 days, 
was examined 8 years later because of abdominal pain and iron-deficiency anemia. Anti-
endomysium antibody (EMA) positivity indicated duodenal biopsy, which revealed gluten-
sensitive enteropathy with subtotal atrophy (Stadium Mars IIIb). Left ventricle size and 
fractional shortening were normal when the diagnosis of celiac disease was established. A 
gluten-free diet resulted in resolution of the iron-deficiency anemia and accelerated growth. 
At the onset of myocarditis, the child was already exposed to a gluten-containing diet. 
Patient 4. This 8-year-old boy with peri-myocarditis characterized by chest pain and a high 
troponin I level (115.9 µg/l) recovered within 2 weeks. Myocardial perfusion scintigraphy 
was performed with negative results. A complete blood count was within the normal range 
though mean corpuscular volume was 75 femtoliters (fL). Seven years later, the symptoms of 
peri-myocarditis recurred with high troponin T (4892 ng/l) and elevated pro-brain natriuretic 
peptide levels (245 pmol/l). Coronary computed tomography ruled out ischemic heart disease. 
The patient’s symptoms disappeared after 3 weeks, but endomysial antibody and tissue 
transglutaminase antibody tests performed because of anemia (hemoglobin: 117 g/l, 
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hematocrit: 0.37, mean corpuscular volume: 63.0 fL) revealed positive results. Duodenal 
biopsy confirmed the diagnosis of celiac disease. 
Patient 7. Normalization of left ventricle function took 510 days in this 1-year-old infant. A 
persistent cough, despite an improving trend in cardiac function, prompted us to investigate 
other etiologies. Forty days after the diagnosis of myocarditis, a sweat test proved positive 
and genetic evaluation revealed two heterozygous mutations of the cystic fibrosis 
transmembrane conductance regulator gene (2184insA in 13a exon and deltaF508) 
(compound heterozygosity), indicating cystic fibrosis.   
Patient 9. This 8-day-old neonate (body weight 3 kg) was admitted because of fever, poor 
appetite and extreme drowsiness.  ST elevation was seen in most leads on electrocardiogram. 
Echocardiography revealed pulmonary hypertension, and mild tricuspid and mitral 
regurgitation. Systolic function of the left ventricle was normal. Decreased left ventricle 
function (fractional shortening: 23%) and a dilated left main (3.3 mm) coronary artery were 
detected on day 3 of his admission. Abdominal ultrasound revealed gallbladder hydrops. On 
the same day, high cardiac troponin T was detected (10,761 ng/ml), and C-reactive protein 
was 3.09 mg/l. The thrombocyte count was 159 × 10
9
/l, which had risen to 446 × 10
9
/l 10 
days later. A stool adenovirus antigen test was positive. Because incomplete Kawasaki 
disease could not be ruled, out intravenous immunoglobulin was administered (2 g/kg). Atrial 
ectopic tachycardia (180–220/min) developed on day 4, resulting in heart failure. Amiodarone 
and milrinone were introduced. Episodes of atrial tachycardia lasted for 5 days. Left ventricle 
function recovered by day 25 after admission, and by the age of 1 year, no coronary dilatation 
or structural heart disease were detectable. 
 
Discussion 
This study demonstrated a cross-section of clinical scenarios characterized by severe heart 
failure, with acute myocarditis as the most likely diagnosis. It was notable that, in four of six 
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long-term survivors, myocarditis preceded the manifestations of other non-cardiac, 
genetically-determined chronic pediatric diseases. Although simple coincidence cannot be 
ruled out, the patients’ altered genetic characters raise the possibility of an association 
between these conditions. 
 Recurrent pericarditis in celiac disease has already been reported in a previous study 
[8]. In one patient in the current study, high troponin levels and cardiac MRI verified 
recurrent peri-myocarditis with residual fibrosis. Curione et al. showed an increased 
prevalence of celiac disease in patients with dilated cardiomyopathy [7], while another report 
suggested that celiac disease, which is often clinically unsuspected, accounts for as many as 
5% of patients with autoimmune myocarditis [6]. Regarding the relationship between celiac 
and cardiac diseases, Elfström et al. found no significant correlation with previous 
myocarditis [9]. It is notable that the median age at the diagnosis of celiac disease was 2 
years, suggesting that a timely diagnosis may have prevented the development of cardiac 
disease. A recent pediatric study showed that children with myocarditis/cardiomyopathy may 
have celiac disease (prevalence 1.8%) [5]. 
 The association between prior myocarditis in patient 3 (an 11-month-old boy) and a 
manifestation of celiac disease 8 years later is questionable. The child was already exposed to 
a gluten-containing diet at the onset of myocarditis. However, because the duration of the 
mechanism leading up to alterations in the myocardium in celiac disease is unknown, a 
relationship between these two conditions cannot be ruled out. 
 Patient 1 in the present study fulfilled the diagnostic criteria for Alström syndrome 
[10], which is a rare autosomal recessive genetic disorder encompassing cone-rod dystrophy 
in infancy, hearing loss, childhood truncal obesity, hyperinsulinemia and type 2 diabetes 
mellitus, hypertriglyceridemia, short stature in adulthood, dilated cardiomyopathy, and 
progressive pulmonary, hepatic, and renal dysfunctions, with development of multiple-organ 
fibrosis [11]. Cardiomyopathy occurs in two-thirds of these patients. Heart failure has two 
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forms: infantile and adult-type onset cardiomyopathies [11]. Many of these infants can have 
apparent recovery of cardiac function for decades [12]. Michaud et al. performed myocardial 
biopsies in two cases and failed to detect inflammatory infiltrates [12], and although 
endomyocardial biopsy is the gold standard for the diagnosis of myocarditis, its sensitivity is 
controversial [13, 14]. However, acute heart failure in infancy that subsequently recovers 
suggests the possibility of myocarditis. Acute heart failure in our patient with Alström 
syndrome was preceded by fever and upper respiratory symptoms. Poor ventricular function 
on echocardiography was associated with elevated levels of cardiac enzymes. However, their 
cardiac function recovered completely and remained normal for 15 years. Although 
endomyocardial biopsy was not performed, this case was highly suggestive of myocarditis.  
 Alström syndrome is a ciliopathy. Primary cilia transport signaling molecules and 
receptors up and down their lengths via intraflagellar transport [15]. The Coxsackie virus 
adenovirus receptor plays an important role in pediatric myocarditis [16], and altered cilial 
function may result in changes in Coxsackie virus adenovirus receptor function.  
 In the present study, the diagnosis of acute myocarditis was based largely on clinical 
features and echocardiographic changes, while electrocardiogram and biological markers 
served as additional non-invasive diagnostic modalities. Complete recovery on long-term 
follow-up also confirmed the diagnosis of myocarditis.  
Compromised natural protective factors are likely to play a pathogenetic role in cystic 
fibrosis, while autoimmune mechanisms may be involved in cases with celiac disease. 
Myocarditis or peri-myocarditis may precede the clinical manifestation of celiac disease. The 
onset of severe cardiac dysfunction in infancy, which subsequently resolves, raises the 
possibility of myocarditis as the initial manifestation of Alström syndrome. No association 
between myocarditis and cystic fibrosis has been described previously. Genetic abnormalities, 
including those involving the HLA-DQ locus, may create susceptibility to myocarditis via 
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direct or indirect mechanisms. The markedly long time to left ventricle recovery (120–510 
days) might have been associated with the presence of comorbidities in three patients.  
 
Limitations  
This study had some limitations. Firstly, it was based on a small sample size and was a purely 
descriptive study. The inclusion criteria were based mainly on clinical features. 
Endomyocardial biopsy and thorough virus analysis including polymerase chain reaction 
analysis would have made the evaluation more comprehensive. However, the prolonged 
follow-up period ruled out most alternative diagnoses (e.g., metabolic cardiomyopathies). 
Nonetheless, even if the diagnosis of myocarditis is questionable, the observation that severe 
heart failure and systolic dysfunction (or regional wall motion abnormality) preceded the 
manifestation of non-cardiac pediatric diseases is noteworthy.  
 
Conclusions 
 In conclusion, to the best of our knowledge, this represents the first pediatric study 
with a prolonged follow-up period focusing on the comorbidities associated with myocarditis. 
The results suggest that myocarditis may precede the manifestations of other chronic pediatric 
diseases, though the pathophysiologies are likely to be heterogeneous. Prolonged follow-up of 
patients who survive myocarditis is therefore recommended not only to detect possible 
progression to cardiomyopathy, but also to identify non-cardiac comorbidities. 
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Table I Characteristics of patients on admission 
 
Patient Age on 
admission 
(year) 
Gender Symptoms 
(onset 
prior 
admission) 
Initial 
FS 
% 
Initial 
LVEDD 
mm 
(Ref. 
value) 
Initial 
MI 
Low 
voltage 
on 
ECG 
CK/Tn 
rise 
Viral 
agent 
1 0.58 female fever, 
tachypnea 
(3 days) 
7 32 
(18-26) 
yes yes yes  
2 1.21 male rhinorrhea,  
cough, lack 
of appetite 
(60 days) 
10 47 
(22–32) 
 
yes no no  
3 0.89 male rhinorrhea 
cough, lack 
of appetite 
(60 days) 
10 51 
(21–31) 
yes no no  
4 8.71 
 
15.69 
(at 
recurrence) 
male chest pain 
(1 day) 
chest pain 
(1 day) 
31 39 
(31–43) 
49 
(37–49) 
no 
 
yes 
no 
 
yes 
yes 
 
yes 
influenza 
A 
 
 
5 1.5 female diarrhea, 
fatigue 
(3 days) 
19 29 
(22–32) 
 
 
yes no yes adeno 
6 1.45 female diarrhea, 
lack of 
appetite, 
fatigue 
(4 days) 
8 42 
(21–31) 
yes yes not 
checked 
 
7 1.11 female rhinorrhea, 
cough, lack 
of appetite, 
fatigue 
(14 days) 
6 40 
(21–31) 
yes yes yes  
8 0.25 female tachypnea, 
fatigue 
(6 h) 
13 25 
(17–25) 
yes yes yes  
9 0.03 male fever, 
drowsiness, 
hypotonia 
(12 h) 
23 20 
(15–21) 
yes no yes adeno
 
(stool) 
Abbreviations: FS = fractional shortening, LVEDD =
 
left ventricular end diastolic dimension 
(M-mode), MI = mitral insufficiency, ECG = electrocardiography, CK/Tn = creatine 
kinase/troponin I or T, adeno = adenovirus 
 
Table I
Table II Treatment and hospital course 
 
Patient Intravenous 
inotropic 
support 
Use of 
IVIG 
Mechanical 
ventilation 
Circulatory 
arrest  
Other 
major 
event 
Death ICU 
LOS 
(days) 
Hosp 
LOS 
(days) 
1 yes no no no  no 7 20 
2 yes no no no LV 
thrombus 
no 20 56 
3 no no no no  no 6 18 
4 no 
no 
no 
yes 
no 
no 
no 
no 
 no 
no 
4 
6 
7 
10 
5 yes no yes yes  yes 2 2 
6 yes no yes yes  yes 2 3 
7 yes yes no no  no 16 41 
8 yes yes yes yes  yes 1 1 
9 yes yes no no AET no 20 30 
Abbreviations: IVIG = Intravenous immunoglobulin, ICU LOS = intensive care unit length of 
stay, Hosp LOS = hospital length of stay, LV = left ventricle, AET = atrial ectopic 
tachycardia 
 
Table II
 Table III Long-term follow-up 
 
Patient  Age at 
disease 
onset  
(years) 
Complications 
during acute 
course 
Time to 
recovery of 
LV 
function* 
(days) 
Follow-up 
duration 
(years) 
Late outcome  Associated non-
cardiac disease 
revealed during 
follow-up 
1 0.58 -  120 16.2 complete 
cardiac 
remission  
Alström syndrome 
8 years later  
2  1.21 LV thrombus, 
cerebral 
embolization  
300 13.78 complete 
cardiac 
remission 
mild 
hemiparesis  
 
3  0.89 -  150 13.71 complete 
cardiac  
remission  
celiac disease 9 
years later  
4 8.71 
15.69 
peri-myocarditis  11 
18 
9.32 7 years later 
recurrent peri-
myocarditis  
celiac disease 7 
years later  
5 1.5 death 2 days      
6 1.45 death 3 days      
7  1.11  510 4.57 complete 
cardiac 
remission  
cystic fibrosis 1 
month later  
8 0.25 death 10 h      
9 0.03 atrial ectopic 
tachycardia 
22 1.6 complete 
cardiac 
remission 
 
 
Abbreviations: LV = Left ventricle, *fractional shortening >30% and normalization of LV 
size or cessation of wall motion abnormality 
 
Table III
